Press Releases

Date	Title and Summary	Additional Formats
Toggle SummaryJuly 28, 2016	Minerva Neurosciences to Report Second Quarter 2016 Financial Results and Business Updates on August 4, 2016	View HTML Minerva Neurosciences to Report Second Quarter 2016 Financial Results and Business Updates on August 4, 2016 15.6 KB
Toggle SummaryJuly 29, 2015	Minerva Neurosciences to Report Second Quarter 2015 Financial Results and Host Conference Call on August 5, 2015	View HTML Minerva Neurosciences to Report Second Quarter 2015 Financial Results and Host Conference Call on August 5, 2015 14.4 KB
Toggle SummaryMarch 1, 2023	Minerva Neurosciences to Report Fiscal Year 2022 Financial Results and Business Updates on March 8, 2023 Management to Host Conference Call BURLINGTON, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will	View HTML PDF Version
Toggle SummaryMarch 1, 2021	Minerva Neurosciences to Report Fiscal 2020 Fourth Quarter and Year End Financial Results and Business Updates on March 8, 2021 Management to host conference call WALTHAM, Mass. , March 01, 2021 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release	View HTML PDF Version
Toggle SummaryMarch 2, 2020	Minerva Neurosciences to Report Fiscal 2019 Fourth Quarter and Year End Financial Results and Business Updates on March 9, 2020 Management to host conference call WALTHAM, Mass. , March 02, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release	View HTML PDF Version
Toggle SummaryMarch 5, 2019	Minerva Neurosciences to Report Fiscal 2018 Fourth Quarter and Year End Financial Results and Business Updates on March 12, 2019 Management to host conference call WALTHAM, Mass. , March 05, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release	View HTML PDF Version
Toggle SummaryMarch 5, 2018	Minerva Neurosciences to Report Fiscal 2017 Fourth Quarter and Year End Financial Results and Business Updates on March 12, 2018 Management to host conference call WALTHAM, Mass. , March 05, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release	View HTML PDF Version
Toggle SummaryMarch 6, 2017	Minerva Neurosciences to Report Fiscal 2016 Fourth Quarter and Year End Financial Results and Business Updates on March 13, 2017	View HTML Minerva Neurosciences to Report Fiscal 2016 Fourth Quarter and Year End Financial Results and Business Updates on March 13, 2017 15.4 KB
Toggle SummaryMarch 7, 2016	Minerva Neurosciences to Report Fiscal 2015 Fourth Quarter and Year End Financial Results and Business Updates on March 14, 2016 Management to Host Conference Call	View HTML Minerva Neurosciences to Report Fiscal 2015 Fourth Quarter and Year End Financial Results and Business Updates on March 14, 2016 18 KB
Toggle SummaryMay 8, 2023	Minerva Neurosciences to Report First Quarter 2023 Financial Results and Business Updates on May 15, 2023 Management to Host Conference Call BURLINGTON, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc.  (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will	View HTML PDF Version

Press Releases

Shareholder Tools